Silexion Therapeutics meeting lacks quorum; share split remains unapproved
Shareholders rejected a plan to increase authorized share capital and a 1-for-15 reverse share split authorization.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.